Follow the 바이넥스 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 바이넥스 has published 38 public disclosures. Market capitalisation: €203.8bn. The latest transaction was disclosed on 3 July 2026 (Other). Among the most active insiders: 더에이블. All data is accessible without an account.
38
Insider Decl.
n/a
Thresholds
n/a
10 ops.
Buy Volume
n/a
4 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,764 of 28,101 companies
19.9
score / 100
Value
17
Quality
23
FCF yld-21%
Earn yld-1.4%
EV/EBITDA25.3x
ROE·
Gross mgn27%
Net mgn-1.9%
Debt/EBITDA7.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
바이넥스 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development and manufacturing of pharmaceutical products.